Committed to healthcare


IDiBE is the Institute of Research, Development, and Innovation in Healthcare Biotechnology in Elche (Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche). We carry out multidisciplinary research, translating our excellent scientific results into products and services for the benefit of society.


We seek to collaborate with hospitals, other research centers and enterprises in the field of Health Biotechnology to deliver high-quality products and technologies to the market. We are committed to serving society and becoming a reference Institute in the field of translational knowledge.


Ana María Fdez-Escamilla y Gregorio Fdez-Ballester participan en un proyecto para el avance del tratamiento antiviral contra SARS-CoV-2

Los investigadores del IDIBE Ana María Fernández-Escamilla y Gregorio Fernández-Ballester participan en un proyecto con un enfoque innovador liderado por Ana Grande, investigadora de la Universidad de Málaga. El trabajo tiene como objetivo...

Aplicaciones correlativas del la Criotomografía de Rayos X. Seminario Ana J. Pérez Berna

El pasado 12 de febrero Ana Joaquina Pérez Berna, científica de la línea MISTRAL del sincrotrón ALBA, impartió un seminario invitada por nuestra compañera Mª del Mar Ortega-Villaizán, con quien ha colaborado en diversas ocasiones. La posibilidad de...

Investigadoras en Biotecnología Sanitaria. Vídeo disponible

El Instituto de Investigación Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE - UMH) ha querido sumarse a las actividades conmemorativas del Día Internacional de La mujer y la niña en la ciencia con una charla coloquio...

Día Internacional de la mujer y la niña en la ciencia en el IDiBE

El IDiBE se une a la celebración del Día Internacional de la mujer y la niña en la ciencia con la jornada "Investigadoras en Biotecnología Sanitaria", que tendrá lugar el próximo día 10 de febrero a las 17:00 horas en modalidad online. Las diversas...

Número especial de International Journal of Molecular Sciences “Bioactives and Nutraceuticals in Metabolic Syndrome 2021”. Plazo abierto para contribuciones.

Nuestros compañeros del IDiBE, los investigadores María Herranz López y Enrique Barrajón Catalán, junto con David Arraez Román, del departamento de Química Analítica de la Universidad de Granada, son los editores invitados del número especial...

Un derivado de la capsaicina, AG1529, capaz de atenuar la excitabilidad de las neuronas sensoriales

Actualmente, no existen tratamientos eficaces que consigan calmar el picor e incluso el dolor que producen diversas alteraciones epidérmicas como es la inflamación, el prurito o la psoriasis. Los investigadores del  Instituto de Investigación,...

Biología epitelial en la revista de la SEBBM

El número 206 de la revista trimestral de la SEBBM (Sociedad Española de Bioquímica y Biología Molecular), correspondiente a diciembre de 2020, incluye un dosier científico dedicado a la biología epitelial que ha coordinado la investigadora del...


We are using our expertise and know-how to find real-world solutions to healthcare challenges.



We are putting out technology and knowledge at the service of society. Are you looking for high-value services or guidance for your R&D projects?



Head start your scientific career and get hands-on experience in a unique environment.



We are excited to share our latest innovations and discoveries with the world. Curious about what we are up to?



The Institute of Research, Development and Innovation in Healthcare Biotechnology of Elche (IDiBE) is a Research Institute of the University Miguel Hernández de Elche, located in the University Campus at Elche, occupying a 4,000 sq. m. of laboratory in the Torregaitán Building.

IDiBE arises from the transformation of the Institute of Molecular and Cellular Biology (IBMC), created by Prof. José Manuel González-Ros, who had the vision of building a multidisciplinary research institute in the University as a sagacious strategy to carry highly competitive and transferable research in the fields of Biotechnology and Biomedicine. This commitment to translational research has been a pivotal hallmark of the Institute since its foundation. As a result, the IDiBE has excelled in its scientific production as well as in the exploitation of the results generated by their members. Furthermore, the interest in transferring the scientific results to society has thrust entrepreneurial actions and the establishment of joint units with private enterprises and local hospitals.

Our previous success has been possible thanks to our philosophy of potentiating collaborations and sharing resources as a way to efficiently exploit the synergies and complementarities of our interdisciplinary team

Our research teams have been very active in securing funding from both governmental and private sources, publishing papers that are widely cited (70% in Q1), training young scientists with the highest scientific and ethical standards as recognized by the mention of excellence and national accreditation of our doctorate program by the Ministry of Education, and disseminating our activities and achievements to society. Notwithstanding, a major impact of the Institute has been:

  • The exploitation of innovative products generated from the research projects in the fields of nutraceuticals, cosmeceuticals, and biotechnology.
  • Having three INDs in clinical development to treat human diseases.
  • Creating 11 spin-off/start-up companies.

To reinforce our transferable and translational activities, the IDiBE has implemented several technological platforms, and organized its research in two core lines:

  • Molecular design and cell signaling.
  • Diagnostic, prognostic and molecular therapy.

Our previous success has been possible thanks to our philosophy of potentiating collaborations and sharing resources as a way to efficiently exploit the synergies and complementarities of our interdisciplinary team. In addition, we are complemented by highly prepared and greatly skilled technical and administrative personnel who pivotally contribute to assisting our researchers technically and administratively, allowing them to focus on accomplishing their scientific objectives.

Although we have walked a long and fruitful way, there is still plenty to accomplish for increasing the IDiBE international exposure and scientific distinction. The General Council has approved a Plan of Action (2019-2022) that establishes the objectives and milestones for the next 4 years, strengthening the original vision, and establishing as a central mission to consolidate our multidisciplinary program of research excellence in healthcare biotechnology, serving as a channel of innovation for the productive and service sectors of our society. For this purpose, we have reinforced our team and reorganized our structure aiming to facilitate the transferable activities, with the undoubtful commitment to become an Institute of research excellence in translational science.

Sincerely yours,

Prof. Antonio Ferrer-Montiel
Director IDiBE